Related Experiment Videos
Different endothelin receptor affinities in dog tissues.
1Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Journal of Receptor Research
|January 1, 1991
Summary
This study reveals varying affinities of endothelin-1 (ET-1) for ET-receptors across different dog tissues. These findings are crucial for understanding ET-1
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Molecular Biology
Background:
- Endothelin (ET) is a potent vasoconstrictor peptide.
- Endothelin-1 (ET-1) plays a significant role in cardiovascular regulation.
- Understanding ET-1 receptor binding is vital for therapeutic development.
Purpose of the Study:
- To investigate the differential binding affinities of endothelin-1 (ET-1) to endothelin receptors (ET-receptors) in various canine tissues.
- To characterize the affinity states of ET-receptors in different dog organs.
Main Methods:
- Preparation of crude microsomal fractions from homogenized dog tissues.
- Incubation of microsomal fractions with radiolabeled 125I-ET-1 and unlabeled ET-1.
- Determination of receptor binding affinities (Kd) and densities (Bmax) using radioligand binding assays.
Main Results:
- High affinity ET-1 binding sites were identified in adrenal, cerebrum, liver, heart, skeletal muscle, and stomach tissues (Kd 50-80 pM).
- Medium affinity receptors were found in cerebellum and spleen (Kd 350 pM).
- Low affinity receptors were observed in lung and kidney (Kd 800-880 pM), with very low affinity sites in heart, intestine, and liver (Kd 3-6 nM).
Conclusions:
- Canine tissues exhibit a diverse range of endothelin-1 receptor affinities.
- These variations in ET-1 receptor binding suggest tissue-specific roles and potential for targeted therapeutic interventions.
- The study provides a comprehensive map of ET-1 receptor distribution and affinity in dogs.